WHO ICTRP trial

A multicenter, single-arm, open-label, phase III clinical study to investigate…

JPRN-jRCT2031230269 · Japan Primary Registries Network (JPRN) · Recruiting

Key facts

Trial ID JPRN-jRCT2031230269
Public title A multicenter, single-arm, open-label, phase III clinical study to investigate the efficacy and safety of GB-0706 in patients developing heparin resistance during cardiovascular surgery using a cardiopulmonary bypass
Scientific title A multicenter, single-arm, open-label, phase III clinical study to investigate the efficacy and safety of GB-0706 in patients developing heparin resistance during cardiovascular surgery using a cardiopulmonary bypass
Primary sponsor Saiki Yoshikatsu
Registry Japan Primary Registries Network (JPRN)
Recruitment status Recruiting
Study type Interventional
Phase 3
Conditions Patients developing heparin resistance during cardiovascular surgery using a cardiopulmonary bypass
Interventions GB-0706 will be administered as the quantity of a single dose is 1,500 IU of antithrombin. If Heparin resistance does not improve after administration of study drug one dose, an additional dose, study drug dose will be administered. (A…
Registration date Jul 29, 2023
Target size 70
Registry page jrct.niph.go.jp

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations